TissueGene Inc (950160)

KOSDAQ

Currency in KRW

101,000

+900(+0.90%)

Closed·02:29:59

Fair Value

Unlock Value

Day's Range

97,900

103,900

52 wk Range

31,250

130,700

950160 Income Statement

Assess the TissueGene income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 950160 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

4,003.15

9,456.04

3,706.06

5,073.44

5,158.71

Total Revenues Growth

aa.aa

+12.58%

+136.22%

-60.81%

+36.9%

+1.68%

Cost Of Revenues

aa.aa

3,611

1,810.77

3,340.14

4,528.3

4,544.21

Gross Profit

aa.aa

392.15

7,645.27

365.92

545.13

614.5

Gross Profit Growth

aa.aa

+20.29%

+1,849.58%

-95.21%

+48.98%

+12.72%

Gross Profit Margin %

aa.aa

9.8%

80.85%

9.87%

10.74%

11.91%

Other Operating Expenses, Total

aa.aa

47,492.74

23,953.01

20,877.07

22,542.82

22,937.63

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+13.39%	-49.56%	-12.84%	+7.98%	+1.75%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	29,889.98	7,122.61	5,635.19	5,611.99	8,549.23
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	15,995.88	14,940.6	13,656.23	15,852.88	13,373.1
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	56.02	224.81	173.93	269.39	237.61

Operating Income

aa.aa

-47,100.59

-16,307.73

-20,511.15

-21,997.69

-22,323.13

Operating Income Growth

aa.aa

-13.34%

+65.38%

-25.78%

-7.25%

-1.48%

EBIT Margin %

aa.aa

-1,176.59%

-172.46%

-553.45%

-433.59%

-432.73%

Net Interest Expenses

aa.aa

-336.77

299.31

1,935.05

950.32

1,670.71

Net Interest Expenses Growth

aa.aa

-915.04%

+188.88%

+546.51%

-50.89%

+75.8%

Interest Expense, Total

aa.aa

-466.46

-371.18

-285.82

-89.85

-89.6

Interest And Investment Income

aa.aa

129.69

670.49

2,220.87

1,040.17

1,760.31

Other Non Operating Expenses, Total

aa.aa

300.89

6,187.8

1,608.31

-12,847.94

-171,951.47

EBT, Excl. Unusual Items

aa.aa

-47,136.47

-9,820.63

-16,967.79

-33,895.3

-192,603.89

Gain (Loss) On Sale Of Assets

aa.aa

-14.87

-3.43

1.02

37.35

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-47,151.34

-9,820.63

-16,971.22

-33,894.28

-192,566.54

EBT, Incl. Unusual Items Growth

aa.aa

-13.17%

+79.17%

-72.81%

-99.72%

-468.14%

EBT, Incl. Unusual Items Margin

aa.aa

-1,177.86%

-103.86%

-457.93%

-668.07%

-3,732.85%

Income Tax Expense

aa.aa

218.27

1,315.58

253.15

-95.47

20.94

Net Income to Company

aa.aa

-47,369.61

-11,136.21

-17,224.37

-33,798.81

-192,587.48

Minority Interest

aa.aa

Net Income

aa.aa

-47,369.61

-11,136.21

-17,224.37

-33,798.81

-192,587.48

Net Income Growth

aa.aa

-13.36%

+76.49%

-54.67%

-96.23%

-469.81%

Net Income Margin %

aa.aa

-1,183.31%

-117.77%

-464.76%

-666.19%

-3,733.25%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-47,369.61

-11,136.21

-17,224.37

-33,798.81

-192,587.48

Basic EPS - Continuing Operations

aa.aa

-773.6

-168

-240.2

-439.2

-2,343.8

Basic EPS - Continuing Operations Growth

aa.aa

-13.03%

+78.28%

-42.98%

-82.85%

-433.65%

Diluted EPS - Continuing Operations

aa.aa

-773.6

-168

-240.2

-439.2

-2,343.8

Diluted EPS - Continuing Operations Growth

aa.aa

-13.03%

+78.28%

-42.98%

-82.85%

-433.65%

Basic Weighted Average Shares Outstanding

aa.aa

61.23

66.29

71.71

76.96

82.17

Diluted Weighted Average Shares Outstanding

aa.aa

61.23

66.29

71.71

76.96

82.17

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-45,549.73

-14,642.75

-19,099.43

-21,189.13

-21,539.11

EBITDA Growth

aa.aa

-14.12%

+67.85%

-30.44%

-10.94%

-1.65%

EBITDA Margin %

aa.aa

-1,137.85%

-154.85%

-515.36%

-417.65%

-417.53%

EBIT

aa.aa

-47,100.59

-16,307.73

-20,511.15

-21,997.69

-22,323.13

* In Millions of KRW (except for per share items)

FAQ

What was TissueGene’s revenue at year end?

At the end of the last reported fiscal year, TissueGene (950160) recorded total revenue of 5,159 million KRW.

How much revenue did TissueGene report in the most recent quarter?

In its most recent quarterly earnings report, TissueGene posted revenue of 861 million KRW.

What was TissueGene’s net income for the year?

For the full year, TissueGene reported net income of -192,587 million KRW.

How much net income did TissueGene post in the last quarter?

In the most recent quarter, TissueGene (950160) posted net income of -123,926 million KRW.

What was TissueGene’s gross profit for the year?

Gross profit for the year was reported at 614 million KRW.

How much gross profit did TissueGene generate last quarter?

TissueGene recorded gross profit of 90 million KRW in its latest quarterly report.

What was TissueGene’s annual operating income?

For the full year, TissueGene (950160) reported operating income of -22,323 million KRW.

What was TissueGene’s operating income last quarter?

Quarterly operating income was -7,972 million KRW.

What was TissueGene’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -7,759 million KRW.

What was the quarter-over-quarter change in EBITDA for TissueGene?

EBITDA changed by -128% million KRW compared to the last quarter.

What is TissueGene’s most recent gross profit margin?

The latest reported gross profit margin for TissueGene (950160) is 10% million KRW.

What is TissueGene’s most recent net income margin?

Net income margin based on recent financials is -14,396% million KRW.

What is TissueGene’s most recent EBIT margin?

TissueGene reported an EBIT margin of -926% million KRW based on current figures.

How did TissueGene’s revenue change compared to the previous quarter?

Revenue changed by -50% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for TissueGene?

In the latest quarter, gross profit changed by -58% million KRW from the previous quarter.

S&P/TSX

33,904.11

-8.82

-0.03%

S&P/TSX 60

1,975.21

-0.65

-0.03%

US 30

49,255.60

-53.7

-0.11%

US 500

7,164.00

+55.7

+0.78%

S&P 500 VIX

18.71

-0.60

-3.11%

DAX

24,128.98

-26.47

-0.11%

Dollar Index

98.36

-0.240

-0.24%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	60.69	-2.44%	13.03M
TC Energy	84.79	+1.63%	10.45M
Enbridge	72.86	+1.32%	10.30M
RBC	239.83	+0.11%	5.17M
Toronto Dominion Bank	143.57	-0.17%	4.39M
Bank of Montreal	208.04	+0.18%	2.62M
Canadian Imperial Bank	149.84	+0.91%	2.56M

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
1933 Industries	0.01	+200.00%	30.00K
Spod Lithium	0.01	+200.00%	2.64K
Montfort Capital	0.0150	+200.00%	3.29M
Voltage Metals	0.01	+200.00%	7.92K
Irwin Naturals	0.30	+150.00%	3.24K
Patriot Gold	0.14	+145.45%	1.80K

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.01	-75.00%	8.00K
New Frontier Ventures	0.030	-68.42%	13.00K
MX Gold Corp	0.0200	-55.56%	27.30K
Armada Mercantile Ltd	0.135	-51.79%	7.00K
Albert Labs International	0.005	-50.00%	1.00K
CAT Strategic	0.0050	-50.00%	1.30K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
Keel Infra	4.49	+0.67%	4.86M
Celestica Inc.	561.01	+4.38%	553.30K
Canopy Growth	1.610	-2.42%	3.25M
Canadian Natural	60.69	-2.44%	13.03M
Air Canada	18.55	+1.59%	2.73M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaa	5.18	+59.83%	8.28
Aaaaaaa	99.34	+55.95%	154.92
A Aaaaaaa	43.78	+50.76%	66.00
Aaaaaaaaaaaa A A	10.75	+45.56%	15.65
Aaaaaaaaaa Aaaaaaa A	30.63	+43.51%	43.96
A Aaaaaaaaaa	23.21	+41.81%	32.91
A Aaaaaa	18.55	+40.09%	25.99

Name	Last	Upside	Fair Value
Aaaaaa	5.18	+59.83%	8.28
Aaaaaaa	99.34	+55.95%	154.92
A Aaaaaaa	43.78	+50.76%	66.00
Aaaaaaaaaaaa A A	10.75	+45.56%	15.65
Aaaaaaaaaa Aaaaaaa A	30.63	+43.51%	43.96
A Aaaaaaaaaa	23.21	+41.81%	32.91
A Aaaaaa	18.55	+40.09%	25.99

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

TissueGene Inc (950160)

950160 Income Statement

FAQ

What was TissueGene’s revenue at year end?

How much revenue did TissueGene report in the most recent quarter?

What was TissueGene’s net income for the year?

How much net income did TissueGene post in the last quarter?

What was TissueGene’s gross profit for the year?

How much gross profit did TissueGene generate last quarter?

What was TissueGene’s annual operating income?

What was TissueGene’s operating income last quarter?

What was TissueGene’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for TissueGene?

What is TissueGene’s most recent gross profit margin?

What is TissueGene’s most recent net income margin?

What is TissueGene’s most recent EBIT margin?

How did TissueGene’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for TissueGene?

Trending Stocks